Berkshire Hathaway Inc. (ZBRK)
Cboe Canada · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 10.74 |
|---|---|
| 52-week range | 9.25 – 10.74 |
| Return, 1 month / 3 months | +7.9% / +9.5% |
| Return, 1 year / 3 years | +10.3% / – |
| Trend | Uptrend |
| RSI (14) | 81 |
| Volatility (1 year) | 14.8% |
| Worst drawdown (1 year) | -9.6% |
| Average daily value traded | 0.02M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Berkshire Hathaway is a holding company based in Omaha, Nebraska, that owns a broad collection of businesses. Its insurance operations include auto insurer GEICO and reinsurance and specialty insurance units. Outside insurance, it owns a railroad, an energy utility business, and many manufacturing, building products, retail and service companies. It also holds large investment portfolios in publicly traded companies. Customers range from individual drivers buying car insurance to businesses and municipalities using its industrial and energy products and services.
Berkshire Hathaway Inc. trades under the code ZBRK on the Cboe Canada in Canada, with its price quoted in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Berkshire Hathaway Inc. (ZBRK) trades on the Cboe Canada in Canada. It last closed at CAD 10.74 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 15 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.3% and over the last three months it rose 9.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Cboe Canada
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.4% | ||
| From 52-week high | 0.0% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.5% | ||
| 6-month return | 14.1% | ||
| 12-month return, skipping the last month | 2.2% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 14.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.6% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CAD | ||
| Zero-volume days | 10.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +7.9% |
| 3 months | +9.5% |
| 6 months | +14.1% |
| 1 year | +10.3% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 10.09 / 9.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.07 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Cboe Canada; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.